iBio Appoints Dr. Timothy Blackwell to New Clinical Advisory Board
July 16, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Jul 16, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, has appointed Timothy...
iBio Expands Commercial Collaboration With Bio-Manguinhos and Fraunhofer
June 17, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Jun 17, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, amended its...
iBio Expands IP Protection of Biotherapeutic Product for Treatment of Fibrosis
June 10, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Jun 10, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, announced the issue by...
iBio European Patent on iBioModulator Technology Emerges From Opposition Period
June 05, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Jun 5, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, has surpassed the opposition...
iBio Receives Patent Allowance in China for Fusion Protein Compositions and Technology
April 24, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Apr 24, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, reported the allowance...
iBio Receives Patent Allowances for Pandemic Influenza Therapeutics
March 27, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Mar 27, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, reported the allowance of two U.S....
iBio to Present at the 26th Annual ROTH Conference on March 10, 2014
March 04, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Mar 4, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, has been invited to present at the...
Phase 1 Clinical Trial Begins for Malaria Vaccine Candidate Based on iBio's Proprietary Technology
February 10, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Feb 10, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, reported the initiation of a...
iBio Adds Biotherapeutic Product for Treatment of Fibrosis to Its Proprietary Product Pipeline
January 30, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Jan 30, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biopharmaceutical products, has added a...
iBio Receives Allowance of Patent for HPV-Related Cancer Vaccine in China
January 21, 2014 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Jan 21, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, has received a notice...